Morningside Venture Investments

Portfolio · 2

Prilenia Therapeutics

Developing New Treatments for Neurodegenerative Diseases

3 rounds $122.5M committed Latest: 2022-04

DeepCure

AI-driven Drug Discovery

Led ★ 1 round $40.0M committed Latest: 2021-11

Investment activity

Q&A

What is Morningside Venture Investments' primary sector focus?

Morningside Venture Investments primarily focuses on the Health Tech & Life Sciences sector, with all of its recorded portfolio companies and investment rounds concentrated in this area.

Which funding stages does Morningside Venture Investments typically participate in?

Morningside Venture Investments has participated in both Series A and Series B funding rounds. They have two recorded Series A rounds and two Series B rounds.

Can you name some notable portfolio companies of Morningside Venture Investments?

Notable portfolio companies of Morningside Venture Investments include DeepCure, an AI-driven drug discovery company, and Prilenia Therapeutics, which is developing treatments for neurodegenerative diseases.

What was Morningside Venture Investments' most recent investment activity?

Morningside Venture Investments' most recent investment activity occurred in April 2022, with one recorded investment round.

When did Morningside Venture Investments make its most recent new portfolio company investment?

Morningside Venture Investments added a new portfolio company in November 2021.

What was the funding stage and amount for DeepCure?

DeepCure, a portfolio company of Morningside Venture Investments, raised a $46M Series A round.

What was the funding stage and amount for Prilenia Therapeutics?

Prilenia Therapeutics, a portfolio company of Morningside Venture Investments, raised a $144.5M Series B round.

What is the typical investment range for Morningside Venture Investments?

Morningside Venture Investments typically invests between $11M and $68.5M.